Omeros Story

<div class='circular--portrait' style='background:#754DEB;color: #F0FFF0;font-size:3em;'>OME</div>
OMER -- USA Stock  

USD 11.80  0.51  4.14%

Omeros Accrued Expenses Turnover is relatively stable at the moment as compared to the past year. Omeros reported last year Accrued Expenses Turnover of 2.91. As of 08/07/2020, Cash and Equivalents Turnover is likely to grow to 26.97, while Average Assets are likely to drop slightly above 86.5 M. Even with relatively invariable basic indicators, Omeros is not utilizing all of its potentials. The new stock price agitation, may contribute to a short-term swings for the retail investors. We currently estimate Omeros as undervalued. The real value is approaching 16.85 per share.
Published over a month ago
View all stories for Omeros | View All Stories
How Omeros (NASDAQ:OMER) weak basic indicators helped with the latest fall?
Our trade recommendations tool can cross-verify current analyst consensus on Omeros and to analyze the firm potential to grow in the current economic cycle. This firm dividends can provide a clue to the current value of the stock. Omeros is not expected to issue dividends this year as it is trying to preserve or re-invest any of the funds available for distribution to stakeholders.
Typically, a company's financial statements are the reports that show the financial position of the company. There are three main documents that fall into the category of financial statements. These documents include Omeros income statement, its balance sheet, and the statement of cash flows. Potential Omeros investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Omeros investors may use each financial statement separately, they are all related. The changes in Omeros's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Omeros's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages. The goal of Omeros fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of Omeros performance into the future periods or doing a reasonable stock valuation. The intrinsic value of Omeros shares is the value that is considered the true value of the share. If the intrinsic value Omeros is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares Omeros. Please read more on our fundamental analysis page.

Are Omeros Earnings Expected to grow?

The future earnings power of Omeros involves the interaction of many company-specific, industry, and economic forces. Earnings estimates embody investors' opinions of Omeros factors such as sales growth, product demand, competitive industry environment, profit margins, and cost controls. Omeros stock prices adjust as these expectations change or are proven wrong. The main thing to remember is that equities with high expected earnings growth tend to underperform the market because it is usually difficult to meet the market's high expectations. Companies with low earnings expectations tend to do better than expected. Please use our latest analysis of Omeros expected earnings.

How Omeros utilizes its cash?

To perform a cash flow analysis of Omeros, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Omeros is receiving and how much cash it distributes out in a given period. The Omeros cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Omeros Net Cash Flow from Operations is relatively stable at the moment as compared to the past year. Omeros reported last year Net Cash Flow from Operations of (60.07 Million)

Omeros Gross Profit

Omeros Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Omeros previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Omeros Gross Profit growth over the last 10 years. Please check Gross Profit in more details.

A Deeper look at Omeros

Institutional investor usually refers to an organization that invests money in Omeros on behalf of clients or other money managers. Buying and selling of large positions of Omeros stock by institutional investors can create supply and demand imbalances that result in sudden price moves of Omeros stock. Let's take a look at how the ownership of Omeros is distributed among investors.

Ownership Allocation

Omeros has a total of 54.51 Million outstanding shares. Over half of Omeros outstanding shares are owned by third-party entities. These third-party entities are typically referred to corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulation than regular investors in Omeros. Please watch out for any change in the institutional holdings of Omeros as this could mean something significant has changed or about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Retail Investors
Retail Investors40.1
 2017 2018 2019 2020 (projected)
Interest Expense11.03 M16.25 M22.66 M24.45 M
Gross Profit63.75 M29.36 M110.94 M119.7 M

Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Omeros has an asset utilization ratio of 231.78 percent. This connotes that the company is making $2.32 for each dollar of assets. An increasing asset utilization means that Omeros is more efficient with each dollar of assets it utilizes for everyday operations.

Current Assets
85 M
Assets Non Current
35.8 M
Current Assets85.04 Million70.35
Assets Non Current35.85 Million29.65

Omeros technical analysis connotes possible bounce back

Latest Risk Adjusted Performance is up to -0.08. Price may fall again. Omeros exhibits very low volatility with skewness of -0.44 and kurtosis of 2.18. However, we advise investors to further study Omeros technical indicators to make sure all market info is available and is reliable.

Our Bottom Line On Omeros

While some firms in the biotechnology industry are either recovering or due for a correction, Omeros may not be as strong as the others in terms of longer-term growth potentials. With a somewhat neutral outlook on your 30 days horizon, it may be better to hold off any trading activity and neither buy new shares of Omeros nor exit your existing holdings in the Stock. It seems the expected volatility has not yet been fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Omeros.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Omeros. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to